RecruitingNot applicableNCT06041204

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Studying Best vitelliform macular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Principal Investigator
Muhamed Alhagrasy, M.D.
Al-Azhar University
Intervention
Letrozole 2.5mg(drug)
Enrollment
200 target
Eligibility
20-40 years · FEMALE
Timeline
20212026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06041204 on ClinicalTrials.gov

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Best vitelliform macular dystrophy

← Back to all trials